
Keywords: آمیلوئید β; CVD; cardiovascular diseases; ROS; reactive oxygen species; MI; myocardial infarction; ECM; extracellular matrix; HIF; hypoxia-inducible factor; VEGF; vascular endothelial growth factor; NF-кB; nuclear factor-кB; DOX; doxorubicin; MDA; malondialdehyde;